Management of Anaemia of CKD

This course covers managing anaemia of CKD using: oral or intravenous iron supplementation, erythropoietin-stimulating agents (ESAs), and blood transfusions.
Format

Self-Paced Online
Course

Authors

Professors Sunil Bhandari & Debasish Banerjee

Duration

2 hours

Audience

Nephrologists and Medical Professionals

Learning objectives

By completing this module, you will gain further insight on:
  • Epidemiology and burden of anaemia in patients with chronic kidney disease (CKD), and the effect on morbidity and mortality
  • Mechanisms driving anaemia of CKD, with a focus on the hypoxia-inducible factor (HIF) pathway
  • The diagnosis of anaemia of CKD (haematological and biological methods)

About the course series

The courses in this series are designed to help healthcare professionals working with patients with kidney disease to build their skills and knowledge. Each module focuses on important topics like cardiovascular renal and metabolic diseases, glomerulonephritis, transplantation, and anaemia. They explain the aetiology, pathology, management, diagnosis, and prognosis of kidney conditions in a clear and practical way.

For medical staff, the content aligns with key parts of the Speciality Training Curriculum for Renal Medicine, created by the Joint Royal Colleges of Physicians Training Board.

This course is a collaboration between the UK Kidney Association and Astellas.

Advance your knowledge

Improve patient outcomes

Professor Sunil Bhandari

Professor Bhandari graduated from the University of Edinburgh and trained in Renal and Transplant Medicine in Yorkshire (UK) and Sydney Australia. He is a Consultant in Nephrology and Honorary Professor at Hull York Medical School (HYMS) and Hull and East Yorkshire Hospitals NHS Trust; Co-Director of UK Advanced Nephrology Course and Deputy Head of School of Medicine for Yorkshire and Humber. Professor Bhandari leads in collaboration a research programme based around renal anaemia, CKD progression and the effects of iron therapy on cardiac and renal function. His ongoing collaborative translational research includes effects of iron therapy in uraemic cardiomyopathy and mitochondrial function.

Professor Debasish Banerjee

Professor Banerjee is the chair of the UK Kidney Association Education & Training Committee. He is a clinical nephrologist managing CKD, dialysis and kidney transplant patients with much expertise in CKD patients with cardiovascular disease, hypertension, heart failure and diabetes. As a member of the European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacotherapy, and following his establishment of a unique kidney failure - heart failure clinic at St George’s, he has created international strategies for managing CKD patients with cardiovascular disease. As part of the Association of British Clinical Diabetologists (ABCD) Renal Association Clinical Study Group, he has assisted in the formulation of national guidelines for the management of CKD patients with the added complication of diabetes. Professor Banerjee also works as the steering committee member of the International Society of Nephrology, Cardio-Renal Group.